Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 14;196(34):E1169.
doi: 10.1503/cmaj.240337.

Perimenopause

Iliana C Lega  1 , Michelle Jacobson  2
Affiliations

Perimenopause

Iliana C Lega et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests:: Michelle Jacobson sits on advisory boards for Astellas, BioSyent, Duchesnay, Eisai, Knight, Lupin, Pfizer, Canadian Menopause Society, and Menopause Foundation of Canada. She has received honoraria, consulting fees, or both, from Astellas, AbbVie, Bayer, BioSyent, Duchesnay, Knight, Lupin, Organon, Pfizer, and Searchlight, grants or contracts from Health Canada and the Canadian Institutes of Health Research, and support to attend meetings from The Society of Obstetricians and Gynaecologists of Canada. No other competing interests were declared.

Similar articles

See all similar articles

References

    1. Harlow SD, Gass M, Hall JE, et al. .; STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab 2012;97:1159–68. - PMC - PubMed
    1. Avis NE, Crawford SL, Greendale G, et al. .; Study of Women’s Health Across the Nation. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015;175:531–9. - PMC - PubMed
    1. “The 2022 Hormone Therapy Position Statement of The North American Menopause Society” Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 2022;29:767–94. - PubMed
    1. Singh S, Best C, Dunn S, et al. . No. 292: Abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can 2018;40:e391–415. - PubMed
    1. Gurka MJ, Vishnu A, Santen RJ, et al. . Progression of metabolic syndrome severity during the menopausal transition. J Am Heart Assoc 2016;5:e003609. doi:10.1161/JAHA.116.003609. - DOI - PMC - PubMed

LinkOut - more resources